Actively Recruiting

Phase 1
All Genders
NCT05807035

Autologous Tumour Vaccine Trial

Led by Vaxine Pty Ltd · Updated on 2025-09-17

30

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

Sponsors

V

Vaxine Pty Ltd

Lead Sponsor

A

Australian Respiratory and Sleep Medicine Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

Phase 1 trial to evaluate the feasibility of preparation, safety, tolerability and response to a personalised autologous tumour vaccine (ATV) formulated with Advax adjuvant when administered to patients with advanced solid cancers either as monotherapy or in combination with other standard of care agents

CONDITIONS

Official Title

Autologous Tumour Vaccine Trial

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically or cytologically confirmed advanced solid cancers or hematological cancers (lymphomas only)
  • Received at least one prior therapy for this disease, unless no standard therapy options exist or patient declines standard therapies after discussion
  • ECOG performance status of 2 or less
  • Ability and willingness to sign informed consent (or parent if a child)
  • Willingness to undergo surgery or fresh tumor biopsy if no suitable tumor tissue is available for vaccine preparation
  • Agreement from primary care team to perform surgery or biopsy for tumor tissue collection
Not Eligible

You will not qualify if you...

  • Receiving any other investigational agents within the preceding 4 weeks
  • Pregnant women
  • No suitable cancer tissue available for vaccine preparation
  • Any condition deemed by the Investigator to make the participant unsuitable for trial entry

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

ARASMI

Adelaide, South Australia, Australia, 5046

Actively Recruiting

Loading map...

Research Team

S

Sharen Pringle, GradCert

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Autologous Tumour Vaccine Trial | DecenTrialz